Roger Dansey
Director/Board Member chez INOVIO PHARMACEUTICALS, INC.
Fortune : 49 732 $ au 31/03/2024
Profil
Actuellement, Roger D. Dansey occupe le poste de directeur médical chez Seagen Inc. Dans le passé, le Dr Dansey a occupé le poste de vice-président de la recherche clinique en oncologie chez Gilead Sciences, Inc. et de vice-président principal et chef du domaine thérapeutique chez Merck Research Laboratories Massachusetts LLC. Le Dr Dansey a obtenu un doctorat de l'université de Witwatersrand.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
16/11/2023 | 3 583 ( 0,02% ) | 49 732 $ | 31/03/2024 |
Postes actifs de Roger Dansey
Sociétés | Poste | Début |
---|---|---|
INOVIO PHARMACEUTICALS, INC. | Director/Board Member | 13/05/2021 |
KRONOS BIO, INC. | Director/Board Member | 20/04/2023 |
Anciens postes connus de Roger Dansey
Sociétés | Poste | Fin |
---|---|---|
SEAGEN INC. | Chief Executive Officer | 09/11/2022 |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Corporate Officer/Principal | 01/04/2018 |
MERCK & CO., INC. | Corporate Officer/Principal | 01/04/2018 |
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/01/2014 |
Formation de Roger Dansey
University of the Witwatersrand | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 4 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
MERCK & CO., INC. | Health Technology |
INOVIO PHARMACEUTICALS, INC. | Health Technology |
KRONOS BIO, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Seagen Inc.
Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |